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Abstract
Background: Prosthetic design for the use in primary total knee arthroplasty has evolved into designs that preserve the
posterior cruciate ligament (PCL) and those in which the ligament is routinely sacrificed (posterior stabilized). In patients
with a functional PCL the decision which design is chosen depends largely on the favour and training of the surgeon.
The objective of this study is to determine whether the patient's perceived outcome and speed of recovery differs
between a posterior cruciate retaining total knee arthroplasty and a posterior stabilized total knee arthroplasty.
Methods/Design: A randomized controlled trial will be conducted. Patients who are admitted for primary unilateral
TKA due to primary osteoarthrosis are included when the following inclusion criteria are met: non-fixed fixed varus or
valgus deformity less than 10 degrees, age between 55 and 85 years, body mass index less than 35 kg/m2 and ASA score
(American Society of Anaesthesiologists) I or II. Patients are randomized in 2 groups. Patients in the posterior cruciate
retaining group will receive a prosthesis with a posterior cut-out for the posterior cruciate ligament and relatively flat
topography. In patients allocated to the posterior stabilized group, in which the posterior cruciate ligament is excised,
the design may substitute for this function by an intercondylar tibial prominence that articulates with the femur in flexion.
Measurements will take place preoperatively and 6 weeks, 3 months, 6 months and 1 year postoperatively.
At all measurement points patient's perceived outcome will be assessed using the Western Ontario and McMaster
Universities Osteoarthritis Index (WOMAC). Secondary outcome measures are quality of life (SF-36) and physician
reported functional status and range of motion as determined with the Knee Society Clinical Rating System (KSS).
Discussion: In the current practice both posterior cruciate retaining and posterior stabilized designs for total knee
arthroplasty are being used. To date no studies have been performed determining whether there is a difference in
patient's perceived outcome between the two designs. Additionally, there is a lack of studies determining the speed of
recovery in both designs as most studies only determine the final outcome. This randomised controlled study has been
designed to determine whether the patient's perceived outcome and speed of recovery differs between a posterior
cruciate retaining total knee arthroplasty and a posterior stabilized total knee arthroplasty.
Trial Registration: The trial is registered in the Netherlands Trial Registry (NTR1673).
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Prosthetic design for the use in primary total knee arthro-
plasty has evolved into designs that preserve the posterior
cruciate ligament (PCL) and those in which the ligament
is routinely sacrificed (posterior stabilized). However,
merely saving the PCL does not provide for normal knee
kinematics unless a proper design is used and surgical
technique is precise [1]. Posterior stabilized implants in
which the ligament is excised may substitute for this func-
tion by an intercondylar tibial prominence that articulates
with the femur in flexion, aiding in femoral roll-back [2].
In femoral roll-back there is a relative internal tibial rota-
tion with flexion as the lateral condyle moves more poste-
riorly due to less constraint [3]. This femoral roll-back
accounts for moving the tibiofemoral contact posteriorly
by approximately 10 mm and represents approximately a
30 percent change in the lever arm of the quadriceps
mechanism. This possible advantage is not present in the
PCL-substituting designs [4].
In the current practice both designs are used. In patients
whith a non functional PCL the posterior stabilised design
is used. However, in patients with a functional PCL the
decision which design is chosen depends largely on the
favour and training of the surgeon. A limited amount of
studies have been performed into the difference in out-
come of the two designs. These studies are characterised
by a small amount of patients, different outcome meas-
ures, poor randomisation and comparing designs of dif-
ferent manufacturers [5]. Range of motion was the only
common outcome parameter; a meta-analysis showed a
difference in range of motion and reproduction angle
favouring posterior stabilized designs over PCL retention
designs one year postoperatively. However, it is uncertain
whether this observation is of clinical relevance [5]. To
date, no studies have been performed determining
whether there is a difference between designs in patient's
perceived outcome. Additionally, there is a lack of studies
determining the speed of recovery in both designs as most
studies only determine the final outcome (e.g. after one
year).
The primary objective of this randomized controlled trial
is to examine whether there is a difference in patient's per-
ceived outcome as determined with The Western Ontario
and McMaster Universities Osteoarthritis Index
(WOMAC) between a patient group receiving a posterior
cruciate retaining total knee arthroplasty compared to a




A randomized controlled trial will be conducted. Patients
that are scheduled for a primary total knee arthroplasty
and apply to the inclusion criteria of the study are
informed about the trial. After consent to participate,
patients are allocated to receive either a posterior cruciate
retaining total knee arthroplasty or a posterior stabilized
total knee arthroplasty. The randomization procedure is
based on sequentially numbered opaque sealed enve-
lopes, produced by an external institution not involved in
the selection, clinical care and evaluation of the patients.
Two orthopaedic surgeons will perform the surgical pro-
cedure, therefore, block randomisation is used. The study
design, procedures and informed consent are approved by
the local Medical Ethical Committee (registration number
2007-23). The trial is registered in the Netherlands Trial
Registry (NTR1673).
Study population
The study will be conducted at the Department of Ortho-
paedic Surgery of the Martini Hospital, which is a large
teaching hospital in the city of Groningen, the Nether-
lands. Patients who are admitted for primary unilateral
TKA due to primary osteoarthrosis are included when the
following inclusion criteria are met: non-fixed fixed varus
or valgus deformity less than 10 degrees, age between 55
and 85 years, body mass index less than 35 kg/m2 and ASA
score (American Society of Anaesthesiologists) I or II.
Patients with secondary osteoarthritis of the knee, rheu-
matic disease, a flexion less than 90 degrees, a flexion con-
tracture over 10 degrees, peripheral neuropathy or a
history of a cerebral vascular accident are excluded. Partic-
ipation in the study is voluntary and informed consent is
required. The inclusion period is planned from January
2008 to January 2010.
If perioperatively an insufficient posterior cruciate liga-
ment is found, the patient will receive a posterior stabi-
lized total knee prosthesis. Analyses will be done
according to the intention-to-treat principle, with a sub-
analysis excluding these conversions. As the incidence of
an insufficient posterior cruciate ligament is higher in
patients with secondary osteoarthritis of the knee, rheu-
matic diseases and a fixed varus or valgus deformity of
over 10 degrees, these are exclusion criteria of our study.
Intervention
The Anatomic Graduated Component (AGC; Biomet, Inc,
Warsaw, IN, USA) is implanted, either the posterior cruci-
ate retaining or the high post posterior stabilized design.
The AGC has been succesfully used in our hospital for
over 20 years. We specifically choose this implant since we
have very good experiences with it, with a high survival
rate. Wordlwide it has been implanted since 1983 with
95%-98% survivorship at 15 years. Several AGC studies
have demonstrated these results [6-8].Page 2 of 4
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ial component with a durable cobalt chrome femoral
component. Regarding the differences between the AGC
designs, the posterior cruciate retaining (PCR) design has
a posterior cut-out for the posterior cruciate ligament and
relatively flat topography. This allows for posterior roll-
back of the femur when the knee is flexed and the poste-
rior cruciate ligament is tensioned.
In the posterior stabilized (PS) design the stabilization is
achieved by a "cam and post" mechanism added to the
prosthesis components. This mechanism replaces the
function of the posterior criciate ligament. The femoral
component has a transverse cam added to the backside of
the prosthesis. The tibial polyethylene plate has a central
polyethylene post placed on the middle of the plate. In
the assembled total knee, the cylindrical cam comes
against the post when the total knee bends. The postthen
forces the cam backwards preventing the forward glide of
the femoral component. In this way the posterior stabi-
lized total knee replaces the function of the posterior cru-
ciate ligament.
PCR and PS designs from other implants are based on the
same biomechanical principles as described above,
although there might be some slight differences in design,
surgical technique and materials used among different
manufacturers. One main advantage of our study, and in
which our study differs from others, is that we compare
one AGC design with another design of the same implant,
which minimizes the variables that differ between the two
groups of patients, especially with respect to surgical tech-
nique and materials used.
The surgical procedure consists of a midline approach.
After the midline skin incision has been made over the
knee joint, the capsule of the joint is exposed. By incising
the joint capsule, the anteromedial arthrotomy is per-
formed. The capsule is incised anteriorly, just superior to
the patella, curving medially from the patella and back
down anteriorly, just medial from the patellar ligament.
Antibiotic prophylaxis with a first-generation cepha-
losporin will be given preoperatively and during the first
twenty-four hours intravenously All patients will be
treated with the same, standardized protocol postopera-
tively, in terms of analgesia and mobilization. Subcutane-
ous low molecular weight heparin is given for 6 weeks
postoperatively as prophylaxis against thrombosis. At day
one after surgery, physiotherapy is started and patients are
mobilized with the aid of two crutches. When patients are
able to walk stairs and make transfers to bed and toilet,
and when the knee flexes at least 90 degrees, they are dis-
charged from the hospital. Physiotherapy will be contin-
ued in the home situation for another 6 weeks.
Measurements
Measurements will take place preoperatively and 6 weeks,
3 months, 6 months and 1 year postoperatively. In this
study the primary outcome parameter is the patient's per-
ceived outcome which will be determined with the West-
ern Ontario and McMaster Universities Osteoarthritis
Index (WOMAC). The WOMAC is the most frequently
used and recommended questionnaire to determine out-
come after TKA [9,10]. The Dutch version has proven to
be reliable and valid [11].
Secondary outcome parameters. Physician reported func-
tional status, including range of motion, will be measured
with the validated Knee Society Clinical Rating System
(KSS) [12]. The 36-item Short Form Health Survey (SF-36)
Dutch language version will be used to assess the health
related quality of life [13]. Moreover, surgical approach,
surgical time and intra-operative blood loss will be
recorded and perioperative complications will be regis-
tered. The study will be double blinded: the KSS will be
completed by a blinded independent observer and the
patient will not be informed about which design is used
during the length of the study.
Sample Size
Sample size calculation is based on the primary outcome
measure (WOMAC). A difference between the two groups
of 15% is considered clinically relevant. With a standard
deviation of 19.0 points, α = 0.05 and power of 80%, 55
patients are needed in each group. With an estimated
drop-out of 10% in total 120 patients are needed, 60
patients in each group.
Statistical analysis
Descriptive statistics (means and standard deviations) will
be used to describe the patient characteristics and out-
come variables at the 5 measurement points.
A GLM repeated measures analysis will be used to deter-
mine whether there is a difference on the primary and sec-
ondary outcome variables between the two groups over
time. A p-value of < 0.05 is considered significant.
Discussion
In the current practice both posterior cruciate retaining
and posterior stabilized designs for total knee arthroplasty
are being used. In patients with a functional PCL the deci-
sion which design is chosen depends largely on the favour
and training of the surgeon. To date, no studies have been
performed determining whether there is a difference
between designs in patient's perceived outcome. Addi-
tionally, there is a lack of studies determining the speed of
recovery in both designs as most studies only determine
the final outcome (e.g. after one year). This study will
overcome these drawbacks.Page 3 of 4
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